Technical Analysis for ARCT - Arcturus Therapeutics Ltd.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 30.50 | 5.12% | 1.49 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| Crossed Above 200 DMA | Bullish | 0.00% | |
| Multiple of Ten Bullish | Other | 0.00% | |
| Weak + Overbought | Other | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Bearish Engulfing | Bearish | 5.12% | |
| Fell Below 200 DMA | Bearish | 5.12% |
| Alert | Time |
|---|---|
| 50 DMA Resistance | about 6 hours ago |
| Rose Above Previous Day's High | about 6 hours ago |
| Outside Day | about 6 hours ago |
| Up 1 ATR | about 6 hours ago |
| Up 5% | about 6 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/08/2024
Arcturus Therapeutics Ltd. Description
Alcobra Ltd is a development-stage biopharmaceutical company. The Company is focused on development and commercialization of its lead product candidates, including MDX and ADAIR. MDX is a oral drug, for the treatment of ADHD and other cognitive disorders, including Fragile X. MDX is a combined rapid onset ER formulation of the chemical pyridoxine pyroglutamate, which is more commonly known as metadoxine. MDX consists of a single bi-layer oral tablet, which includes both a rapid onset release metadoxine formulation and a slow release metadoxine formulation together providing the desired dual release profile. The new extended-release formulation prolongs the human plasma levels of metadoxine for up to 12 hours, which results in enhanced efficacy benefits. ADAIR is an oral, semi-solid, liquid-filled, hard gelatin capsule of an abuse-deterrent IR formulation of dextroamphetamine sulfate, which is manufactured as 10 mg capsules.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Health Sciences Drugs Pharmacology Euphoriants Amphetamine Cognitive Disorders Glutamate Tablet Adhd Taar1 Agonists
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 43.81 |
| 52 Week Low | 17.5238 |
| Average Volume | 521,119 |
| 200-Day Moving Average | 29.42 |
| 50-Day Moving Average | 30.84 |
| 20-Day Moving Average | 27.43 |
| 10-Day Moving Average | 28.14 |
| Average True Range | 1.77 |
| RSI (14) | 57.08 |
| ADX | 24.04 |
| +DI | 25.40 |
| -DI | 13.77 |
| Chandelier Exit (Long, 3 ATRs) | 25.68 |
| Chandelier Exit (Short, 3 ATRs) | 30.72 |
| Upper Bollinger Bands | 29.87 |
| Lower Bollinger Band | 25.00 |
| Percent B (%b) | 1.13 |
| BandWidth | 17.76 |
| MACD Line | -0.34 |
| MACD Signal Line | -0.97 |
| MACD Histogram | 0.6292 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 33.70 | ||||
| Resistance 3 (R3) | 33.50 | 32.25 | 33.16 | ||
| Resistance 2 (R2) | 32.25 | 31.43 | 32.34 | 32.98 | |
| Resistance 1 (R1) | 31.37 | 30.93 | 31.81 | 31.57 | 32.81 |
| Pivot Point | 30.12 | 30.12 | 30.34 | 30.21 | 30.12 |
| Support 1 (S1) | 29.24 | 29.30 | 29.68 | 29.44 | 28.19 |
| Support 2 (S2) | 27.99 | 28.80 | 28.08 | 28.02 | |
| Support 3 (S3) | 27.11 | 27.99 | 27.84 | ||
| Support 4 (S4) | 27.31 |
